Pharming Group N.V. (PHAR)
NASDAQ: PHAR · IEX Real-Time Price · USD
8.09
+0.04 (0.50%)
At close: Jul 2, 2024, 3:57 PM
8.32
+0.23 (2.84%)
After-hours: Jul 2, 2024, 4:00 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $542.12 million as of July 2, 2024. Its market cap has decreased by -24.84% in one year.
Market Cap
542.12M
Enterprise Value
504.75M
1-Year Change
-24.84%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since December 23, 2020, Pharming Group's market cap has decreased from $1.07B to $542.12M, a decrease of -49.13%. That is a compound annual growth rate of -17.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 540.20M | -28.30% |
| Dec 29, 2023 | 753.40M | 5.28% |
| Dec 30, 2022 | 715.60M | 25.30% |
| Dec 31, 2021 | 571.10M | -41.09% |
| Dec 31, 2020 | 969.50M | -9.02% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 580.89M |
| REGENXBIO | 576.30M |
| Celcuity | 574.96M |
| Humacyte | 571.60M |
| Paragon 28 | 567.39M |
| Savara | 556.90M |
| IRadimed | 556.46M |
| Replimune Group | 552.74M |